![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, July 23, 2013 7:48:05 AM
If we take the table of events/catalysts below, extracted from the Dr. Seymour's video, and we can agree/edit all event catalysts, lets put it in front of everyone, every week, and I think "information" will start eroding uncertainty, resistance and shorts in front of our NNVC Express. It is so easy to cut/paste FAQ, right?
Our moderator, the Big Kahuna, writes regularly to answer questions with good estimates. If we agree to a table of activities, events, milestones, we post them regularly with A GOOD DISCLAIMER, if needed.
This train will make short stops on the way up but don't get out and stay out for too long. At some point in the not so distant future NNVC will pull a "Hillbilly" on us. ---
I for one believe that shortly after Phase I human trials results (2014) NNVC gives indication that they've found another location for a large cGMP plant. That plant could be ready by the end of (2015).
-----------------------------------------------------------------
Once the cGMP pilot plant is complete the Project Management group will continue steering a series of activities forward according to a timeline. The completion of the cGMP pilot plant in 4Q 2013 will be a milestone among others.
Some of the known Catalysts are: ---
Approval for DengueCide® orphan status ~ 3Q 2013
Well over 100 countries to approve "first in class" patent applications ~ 4Q 2013
Milestones -
-cGMP/R&D Center Shelton CT integration completes ~ 4Q 2013
-Commision new cGMP plant ~ 4Q 2013 (equipment moved in/3 identical test batches)
-Receive initial results toxicology studies FluCide ~ 4Q 2013
-Prepare IND for submission to regulatory authorities ~ 4Q 2013
Other guesstimated catalysts -
FluCide® production of test "identical" batches begins ~ 1Q 2014
FluCide® human trials Phase I/IIa begin ~ 3Q 2014
FluCide® human trials Phase IIb/III ~ 1H 2015
More guesstimates:
Potential for blockbuster drugs in pipeline begins realization could very well happen 1H 2015; If Allan's (www.allantrends.com) NNVC's nav estimation is correct (NNVC's nav at $100/share) it could quickly become a reality in 2015. Do you recall Dr. Seymour makes mention of some phase(s)/human trials taking only a "few short months".
A time will come, soon, when you will hear others in astonishment, asking, "...when did these ball players get here?"
Watch the video (above...known catalysts...), as many times as necessary. Do you read the same information from this video as I do? Do you see the same up and coming events for NNVC as I do? Will Big Pharma act in anticipation of results of Phase I or will they act after Phase I? My guesstimates are exactly that, guesses, based on a seasoned Project Management group, derived from Dr. Seymour's phrase, "... we are on a path, it is like being on a track,...", like a train of events, making scheduled stops, but coming our way on-time.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM